Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs

Abstrait

Effect to the Synergistic Action of Photobiomodulation and Therapeutic Ultrasound on Psoriatic Arthritis and Fibromyalgia - Case Report

Ana Carolina Negraes Canelada, Vanessa Garcia, Tiago Zuccolotto Rodrigues, Viviane Brocca de Souza, Vitor Hugo Panhoca, Antonio Eduardo de Aquino Junior, Vanderlei Salvador Bagnato

Psoriasis is a chronic inflammatory, autoimmune disease that affects the skin, and over time, can also affect the joints, evolving into psoriatic arthritis. The pathogenesis is related to genetic conditions and etiopathogenic mechanisms, which affect about 2% of the world population. In the aspect of psoriatic arthritis, the chronic peripheral inflammatory process affects the joints, bones and muscles, generating hyperalgesia and allodynia. This process can lead to the development of fibromyalgia, which is a chronic disease with generalized muscle pain, related by genetic and psychosocial factors and concomitant diseases, such as psoriatic arthritis. In this study, the synergistic interaction of photobiomodulation and therapeutic ultrasound was used in a picture of associated diseases of psoriasis, psoriatic arthritis and fibromyalgia. In the evaluation mechanism, the Fibromyalgia Impact Questionnaire (FIQ), Quality of Life in Psoriatic Arthritis (PsAQoL) and the Visual Analogue Scale (VAS) were used. It was observed, in a period of 14 sessions, that the synergistic action of photobiomodulation and therapeutic ultrasound, presented benefits and improvement in the patient's quality of life (FIQ and PsAQoL), as well as pain reduction (VAS).